{"entity":{"type":"insider","cik":"0001280154","url":"/insider/0001280154","json_url":"/insider/0001280154.json","name":"OCAMPO CHRISTINE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":19,"first":"2005-05-19","last":"2017-05-11","span_basis":"filed_date"},"name_variants":[{"name":"OCAMPO CHRISTINE","source":"filing","n_filings":19,"first_seen":"2005-05-19","last_seen":"2017-05-11"}],"transactions":[{"id":5096425,"accession":"0000899243-17-012930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-012930","line_url":"/filing/0000899243-17-012930#line-1","is_derivative":false,"issuer_cik":"0001280154","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001280154","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10010.0,"shares_display":"10,010","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":99999.9,"total_display":"99,999.90","total_whole":"100,000","shares_owned_after":21590.0,"shares_owned_after_display":"21,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-11","scope":"insider"},{"id":6742916,"accession":"0001209191-14-076841","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-076841","line_url":"/filing/0001209191-14-076841#line-5","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5780.0,"shares_display":"5,780","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":97855.4,"total_display":"97,855.40","total_whole":"97,855","shares_owned_after":108797.0,"shares_owned_after_display":"108,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-18","scope":"insider"},{"id":6742913,"accession":"0001209191-14-076841","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-076841","line_url":"/filing/0001209191-14-076841","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":508200.0,"total_display":"508,200.00","total_whole":"508,200","shares_owned_after":114577.0,"shares_owned_after_display":"114,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-18","scope":"insider","n_lines":2},{"id":7055335,"accession":"0001209191-14-064836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-064836","line_url":"/filing/0001209191-14-064836#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":11.81,"price_display":"11.81","price_state":"stated","total_value":24564.8,"total_display":"24,564.80","total_whole":"24,565","shares_owned_after":77791.0,"shares_owned_after_display":"77,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-24","filed_date":"2014-10-24","scope":"insider"},{"id":6447957,"accession":"0001209191-14-058496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-058496","line_url":"/filing/0001209191-14-058496#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":9.45,"price_display":"9.45","price_state":"stated","total_value":519750.0,"total_display":"519,750.00","total_whole":"519,750","shares_owned_after":79871.0,"shares_owned_after_display":"79,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-17","scope":"insider"},{"id":6679140,"accession":"0001209191-14-054896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-054896","line_url":"/filing/0001209191-14-054896#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2110.0,"shares_display":"2,110","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":12871.0,"total_display":"12,871.00","total_whole":"12,871","shares_owned_after":79871.0,"shares_owned_after_display":"79,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-26","filed_date":"2014-08-28","scope":"insider"},{"id":6443237,"accession":"0001209191-14-034817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-034817","line_url":"/filing/0001209191-14-034817#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11900.0,"shares_display":"11,900","price_per_share":4.88,"price_display":"4.88","price_state":"stated","total_value":58072.0,"total_display":"58,072.00","total_whole":"58,072","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-16","filed_date":"2014-05-16","scope":"insider"},{"id":6443234,"accession":"0001209191-14-034817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-034817","line_url":"/filing/0001209191-14-034817#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25596.0,"shares_display":"25,596","price_per_share":5.13,"price_display":"5.13","price_state":"stated","total_value":131307.48,"total_display":"131,307.48","total_whole":"131,307","shares_owned_after":81981.0,"shares_owned_after_display":"81,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-16","scope":"insider"},{"id":4231684,"accession":"0001209191-13-058259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-058259","line_url":"/filing/0001209191-13-058259#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2450.0,"shares_display":"2,450","price_per_share":2.6308,"price_display":"2.63","price_state":"stated","total_value":6445.46,"total_display":"6,445.46","total_whole":"6,445","shares_owned_after":63202.0,"shares_owned_after_display":"63,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-18","filed_date":"2013-12-20","scope":"insider"},{"id":4424051,"accession":"0001209191-13-027420","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-027420","line_url":"/filing/0001209191-13-027420","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77700.0,"shares_display":"77,700","price_per_share":3.2850651222651224,"price_display":"3.29","price_state":"stated","total_value":255249.56,"total_display":"255,249.56","total_whole":"255,250","shares_owned_after":65652.0,"shares_owned_after_display":"65,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider","n_lines":2},{"id":2966794,"accession":"0001209191-12-055927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055927","line_url":"/filing/0001209191-12-055927#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2845.0,"shares_display":"2,845","price_per_share":2.551,"price_display":"2.55","price_state":"stated","total_value":7257.595,"total_display":"7,257.60","total_whole":"7,258","shares_owned_after":55401.0,"shares_owned_after_display":"55,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":3555951,"accession":"0001209191-12-046187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-046187","line_url":"/filing/0001209191-12-046187#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":3.4896,"price_display":"3.49","price_state":"stated","total_value":226824.0,"total_display":"226,824.00","total_whole":"226,824","shares_owned_after":58246.0,"shares_owned_after_display":"58,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-17","filed_date":"2012-09-19","scope":"insider"},{"id":3316718,"accession":"0001209191-12-016317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-016317","line_url":"/filing/0001209191-12-016317#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.5983,"price_display":"2.60","price_state":"stated","total_value":7794.9,"total_display":"7,794.90","total_whole":"7,795","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-06","filed_date":"2012-03-07","scope":"insider"},{"id":9019378,"accession":"0001209191-11-059752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059752","line_url":"/filing/0001209191-11-059752#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2676.0,"shares_display":"2,676","price_per_share":2.3811,"price_display":"2.38","price_state":"stated","total_value":6371.8236,"total_display":"6,371.82","total_whole":"6,372","shares_owned_after":38246.0,"shares_owned_after_display":"38,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-02","filed_date":"2011-12-06","scope":"insider"},{"id":8961150,"accession":"0001209191-11-055813","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-11-055813","line_url":"/filing/0001209191-11-055813#line-5","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92250.0,"shares_display":"92,250","price_per_share":2.6239,"price_display":"2.62","price_state":"stated","total_value":242054.775,"total_display":"242,054.78","total_whole":"242,055","shares_owned_after":40922.0,"shares_owned_after_display":"40,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-11","filed_date":"2011-11-14","scope":"insider"},{"id":7306630,"accession":"0001209191-10-059051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-059051","line_url":"/filing/0001209191-10-059051#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13660.0,"shares_display":"13,660","price_per_share":3.79,"price_display":"3.79","price_state":"stated","total_value":51771.4,"total_display":"51,771.40","total_whole":"51,771","shares_owned_after":39572.0,"shares_owned_after_display":"39,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-06","filed_date":"2010-12-08","scope":"insider"},{"id":7261160,"accession":"0001209191-10-058460","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-10-058460","line_url":"/filing/0001209191-10-058460","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23350.0,"shares_display":"23,350","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":94100.5,"total_display":"94,100.50","total_whole":"94,101","shares_owned_after":53232.0,"shares_owned_after_display":"53,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-03","filed_date":"2010-12-03","scope":"insider","n_lines":2},{"id":7261152,"accession":"0001209191-10-058460","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-058460","line_url":"/filing/0001209191-10-058460#line-3","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":99600.0,"total_display":"99,600.00","total_whole":"99,600","shares_owned_after":53232.0,"shares_owned_after_display":"53,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-02","filed_date":"2010-12-03","scope":"insider"},{"id":7655666,"accession":"0001209191-10-042615","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-042615","line_url":"/filing/0001209191-10-042615","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28250.0,"shares_display":"28,250","price_per_share":3.1055465486725664,"price_display":"3.11","price_state":"stated","total_value":87731.69,"total_display":"87,731.69","total_whole":"87,732","shares_owned_after":54563.0,"shares_owned_after_display":"54,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-11","filed_date":"2010-08-13","scope":"insider","n_lines":2},{"id":7309285,"accession":"0001209191-10-017673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-017673","line_url":"/filing/0001209191-10-017673","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15518.0,"shares_display":"15,518","price_per_share":2.080366026549813,"price_display":"2.08","price_state":"stated","total_value":32283.12,"total_display":"32,283.12","total_whole":"32,283","shares_owned_after":42182.0,"shares_owned_after_display":"42,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-16","filed_date":"2010-03-17","scope":"insider","n_lines":4},{"id":5762335,"accession":"0001209191-09-011519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-011519","line_url":"/filing/0001209191-09-011519","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Finance","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11900.0,"shares_display":"11,900","price_per_share":0.43831932773109245,"price_display":"0.44","price_state":"stated","total_value":5216.0,"total_display":"5,216.00","total_whole":"5,216","shares_owned_after":69400.0,"shares_owned_after_display":"69,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-24","filed_date":"2009-02-25","scope":"insider","n_lines":2},{"id":1508274,"accession":"0001209191-05-027085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-027085","line_url":"/filing/0001209191-05-027085","is_derivative":false,"issuer_cik":"0000863680","issuer_name":"CARDIOGENESIS CORP /CA","issuer_ticker":"CGCP","issuer_name_source":null,"issuer_url":"/issuer/0000863680","owner_cik":"0001280154","owner_name":"OCAMPO CHRISTINE","owner_display_name":"OCAMPO CHRISTINE","owner_url":"/insider/0001280154","role":"Officer (V.P., Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (V.P., Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.435,"price_display":"0.44","price_state":"stated","total_value":8700.0,"total_display":"8,700.00","total_whole":"8,700","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-19","filed_date":"2005-05-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Novus Therapeutics, Inc.","url":"/issuer/0001404281","role":"Officer","n_filings":1,"first_seen":"2017-05-11","last_seen":"2017-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS, INC.","url":"/issuer/0000858803","role":"Officer (Vice President, Finance)","n_filings":17,"first_seen":"2009-02-25","last_seen":"2014-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000863680","name":"CARDIOGENESIS CORP /CA","url":"/issuer/0000863680","role":"Officer (V.P., Chief Financial Officer)","n_filings":1,"first_seen":"2005-05-19","last_seen":"2005-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280154","retrieved_at":"2026-08-24T13:13:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}